StreetInsider.com News Articles

Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards

Tue, 10 Mar 2026 07:00:00 -0400

Updated FDA Framework Bolsters Scientific Validation Pathway for Else's Plant‑Based Formula and Accelerates U.S. Commercialization Potential

VANCOUVER, BC, March 10, 2026 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) ("Else" or the "Company"), a pioneer in whole-food plant-based, non-soy, non-dairy nutrition for early childhood nutrition, today announced that the U.S. Food and Drug Administration (FDA) has formally listed Protein Efficiency Ratio (PER) Rat Bioassay Study Guidance as an active topic within its Foods Program regulatory agenda.

Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards

Tue, 10 Mar 2026 07:00:00 -0400

Updated FDA Framework Bolsters Scientific Validation Pathway for Else's Plant‑Based Formula and Accelerates U.S. Commercialization Potential

Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards

Tue, 10 Mar 2026 07:00:00 -0400

Updated FDA Framework Bolsters Scientific Validation Pathway for Else's Plant‑Based Formula and Accelerates U.S. Commercialization Potential

Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards

Tue, 10 Mar 2026 07:00:00 -0400

Updated FDA Framework Bolsters Scientific Validation Pathway for Else's Plant‑Based Formula and Accelerates U.S. Commercialization Potential

Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards

Tue, 10 Mar 2026 07:00:00 -0400

Updated FDA Framework Bolsters Scientific Validation Pathway for Else's Plant‑Based Formula and Accelerates U.S. Commercialization Potential

Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards

Tue, 10 Mar 2026 07:00:00 -0400

Updated FDA Framework Bolsters Scientific Validation Pathway for Else's Plant‑Based Formula and Accelerates U.S. Commercialization Potential

Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards

Tue, 10 Mar 2026 07:00:00 -0400

Updated FDA Framework Bolsters Scientific Validation Pathway for Else's Plant‑Based Formula and Accelerates U.S. Commercialization Potential

Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards

Tue, 10 Mar 2026 07:00:00 -0400

Updated FDA Framework Bolsters Scientific Validation Pathway for Else's Plant‑Based Formula and Accelerates U.S. Commercialization Potential

Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards

Tue, 10 Mar 2026 07:00:00 -0400

Updated FDA Framework Bolsters Scientific Validation Pathway for Else's Plant‑Based Formula and Accelerates U.S. Commercialization Potential

Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards

Tue, 10 Mar 2026 07:00:00 -0400

Updated FDA Framework Bolsters Scientific Validation Pathway for Else's Plant‑Based Formula and Accelerates U.S. Commercialization Potential

Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards

Tue, 10 Mar 2026 07:00:00 -0400

Updated FDA Framework Bolsters Scientific Validation Pathway for Else's Plant‑Based Formula and Accelerates U.S. Commercialization Potential

Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards

Tue, 10 Mar 2026 07:00:00 -0400

Updated FDA Framework Bolsters Scientific Validation Pathway for Else's Plant‑Based Formula and Accelerates U.S. Commercialization Potential

Else Nutrition Surpasses One Million Cans Sold Since Launch

Thu, 29 Jan 2026 07:00:00 -0400

Milestone underscores accelerating consumer demand for clean, dairy-free nutrition alternatives

VANCOUVER, BC, Jan. 29, 2026 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTC: BABYF) (FSE: 0YL.F) ("Else" or the "Company"), a pioneer in whole-food plant-based, non-soy, non-dairy nutrition for early childhood nutrition, proudly announces it has surpassed one million total cans sold across its toddler and kids powder product lines since launching.

Else Nutrition Surpasses One Million Cans Sold Since Launch

Thu, 29 Jan 2026 07:00:00 -0400

Milestone underscores accelerating consumer demand for clean, dairy-free nutrition alternatives

Else Nutrition Surpasses One Million Cans Sold Since Launch

Thu, 29 Jan 2026 07:00:00 -0400

Milestone underscores accelerating consumer demand for clean, dairy-free nutrition alternatives

Else Nutrition Surpasses One Million Cans Sold Since Launch

Thu, 29 Jan 2026 07:00:00 -0400

Milestone underscores accelerating consumer demand for clean, dairy-free nutrition alternatives

Else Nutrition Surpasses One Million Cans Sold Since Launch

Thu, 29 Jan 2026 07:00:00 -0400

Milestone underscores accelerating consumer demand for clean, dairy-free nutrition alternatives

Else Nutrition Surpasses One Million Cans Sold Since Launch

Thu, 29 Jan 2026 07:00:00 -0400

Milestone underscores accelerating consumer demand for clean, dairy-free nutrition alternatives

Else Nutrition Surpasses One Million Cans Sold Since Launch

Thu, 29 Jan 2026 07:00:00 -0400

Milestone underscores accelerating consumer demand for clean, dairy-free nutrition alternatives

Else Nutrition Surpasses One Million Cans Sold Since Launch

Thu, 29 Jan 2026 07:00:00 -0400

Milestone underscores accelerating consumer demand for clean, dairy-free nutrition alternatives

Else Nutrition Announces Results from Annual General Meeting of Shareholders

Mon, 12 Jan 2026 17:14:00 -0400

VANCOUVER, BC, Jan. 12, 2026 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) (the "Company") announces that at its annual general meeting of shareholders held on December 29, 2025 (the "Meeting"), all resolutions put to its shareholders were passed. A total of 6,473,877 or 17.30% of the Company's issued and outstanding shares were represented at the Meeting.

Else Nutrition Announces Results from Annual General Meeting of Shareholders

Mon, 12 Jan 2026 17:14:00 -0400

Else Nutrition Announces Results from Annual General Meeting of Shareholders

Mon, 12 Jan 2026 17:14:00 -0400

Else Nutrition Announces Results from Annual General Meeting of Shareholders

Mon, 12 Jan 2026 17:14:00 -0400

Else Nutrition Announces Results from Annual General Meeting of Shareholders

Mon, 12 Jan 2026 17:14:00 -0400